Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study.

Ruth Elizabeth Watkinson, Richard Williams, Stephanie Gillibrand, Caroline Sanders, Matt Sutton
Author Information
  1. Ruth Elizabeth Watkinson: Health Organisation, Policy and Economics, Centre for Primary Care and Health Services Research, University of Manchester, Manchester, United Kingdom. ORCID
  2. Richard Williams: NIHR Greater Manchester Patient Safety Translational Research Centre, Manchester Academic Health Science Centre, University of Manchester, Manchestehr, United Kingdom. ORCID
  3. Stephanie Gillibrand: Health Organisation, Policy and Economics, Centre for Primary Care and Health Services Research, University of Manchester, Manchester, United Kingdom.
  4. Caroline Sanders: NIHR Applied Research Collaboration Greater Manchester, Centre for Primary Care and Health Services Research, University of Manchester, Manchester, United Kingdom. ORCID
  5. Matt Sutton: Health Organisation, Policy and Economics, Centre for Primary Care and Health Services Research, University of Manchester, Manchester, United Kingdom. ORCID

Abstract

BACKGROUND: COVID-19 vaccine uptake is lower amongst most minority ethnic groups compared to the White British group in England, despite higher COVID-19 mortality rates. Here, we add to existing evidence by estimating inequalities for 16 minority ethnic groups, examining ethnic inequalities within population subgroups, and comparing the magnitudes of ethnic inequalities in COVID-19 vaccine uptake to those for routine seasonal influenza vaccine uptake.
METHODS AND FINDINGS: We conducted a retrospective cohort study using the Greater Manchester Care Record, which contains de-identified electronic health record data for the population of Greater Manchester, England. We used Cox proportional hazards models to estimate ethnic inequalities in time to COVID-19 vaccination amongst people eligible for vaccination on health or age (50+ years) criteria between 1 December 2020 and 18 April 2021 (138 days of follow-up). We included vaccination with any approved COVID-19 vaccine, and analysed first-dose vaccination only. We compared inequalities between COVID-19 and influenza vaccine uptake adjusting by age group and clinical risk, and used subgroup analysis to identify populations where inequalities were widest. The majority of individuals (871,231; 79.24%) were White British. The largest minority ethnic groups were Pakistani (50,268; 4.75%), 'other White background' (43,195; 3.93%), 'other ethnic group' (34,568; 3.14%), and Black African (18,802; 1.71%). In total, 83.64% (919,636/1,099,503) of eligible individuals received a COVID-19 vaccine. Uptake was lower compared to the White British group for 15 of 16 minority ethnic groups, with particularly wide inequalities amongst the groups 'other Black background' (hazard ratio [HR] 0.42, 95% CI 0.40 to 0.44), Black African (HR 0.43, 95% CI 0.42 to 0.44), Arab (HR 0.43, 95% CI 0.40 to 0.48), and Black Caribbean (HR 0.43, 95% CI 0.42 to 0.45). In total, 55.71% (419,314/752,715) of eligible individuals took up influenza vaccination. Compared to the White British group, inequalities in influenza vaccine uptake were widest amongst the groups 'White and Black Caribbean' (HR 0.63, 95% CI 0.58 to 0.68) and 'White and Black African' (HR 0.67, 95% CI 0.63 to 0.72). In contrast, uptake was slightly higher than the White British group amongst the groups 'other ethnic group' (HR 1.11, 95% CI 1.09 to 1.12) and Bangladeshi (HR 1.08, 95% CI 1.05 to 1.11). Overall, ethnic inequalities in vaccine uptake were wider for COVID-19 than influenza vaccination for 15 of 16 minority ethnic groups. COVID-19 vaccine uptake inequalities also existed amongst individuals who previously took up influenza vaccination. Ethnic inequalities in COVID-19 vaccine uptake were concentrated amongst older and extremely clinically vulnerable adults, and the most income-deprived. A limitation of this study is the focus on uptake of the first dose of COVID-19 vaccination, rather than full COVID-19 vaccination.
CONCLUSIONS: Ethnic inequalities in COVID-19 vaccine uptake exceeded those for influenza vaccine uptake, existed amongst those recently vaccinated against influenza, and were widest amongst those with greatest COVID-19 risk. This suggests the COVID-19 vaccination programme has created additional and different inequalities beyond pre-existing health inequalities. We suggest that further research and policy action is needed to understand and remove barriers to vaccine uptake, and to build trust and confidence amongst minority ethnic communities.

References

JMIR Public Health Surveill. 2021 Sep 17;7(9):e30010 [PMID: 34265740]
Brain Behav Immun. 2021 May;94:41-50 [PMID: 33713824]
Vaccine. 2011 Sep 2;29(38):6472-84 [PMID: 21756960]
Vaccine. 2021 Oct 8;39(42):6256-6261 [PMID: 34544601]
Lancet. 1971 Feb 27;1(7696):405-12 [PMID: 4100731]
Lancet. 2021 May 8;397(10286):1725-1735 [PMID: 33901423]
Lancet Public Health. 2021 Mar;6(3):e145-e154 [PMID: 33516278]
Nat Commun. 2021 Jun 17;12(1):3698 [PMID: 34140469]
Psychol Med. 2022 Oct;52(14):3127-3141 [PMID: 33305716]
J Epidemiol Community Health. 2020 Nov;74(11):964-968 [PMID: 32535550]
BMJ. 2020 Nov 13;371:m4425 [PMID: 33187972]
Health Expect. 2021 Aug;24(4):1158-1167 [PMID: 33942948]
BMJ Open. 2021 Jul 23;11(7):e053402 [PMID: 34301672]
Lancet Reg Health Eur. 2021 Oct;9:100180 [PMID: 34308406]
BMJ Open. 2014 Aug 12;4(8):e005764 [PMID: 25116456]
Psychol Med. 2023 Jan;53(1):236-247 [PMID: 33843509]
Ethn Health. 2022 Oct;27(7):1555-1574 [PMID: 34092149]
Biometrics. 1997 Sep;53(3):1151-6 [PMID: 9333345]
BMJ. 2021 Feb 26;372:n513 [PMID: 33637577]
Lancet Infect Dis. 2021 Sep;21(9):1204-1206 [PMID: 34384531]

MeSH Term

Adolescent
Adult
Aged
Aged, 80 and over
COVID-19
COVID-19 Vaccines
Cohort Studies
Ethnicity
Female
Humans
Influenza Vaccines
Influenza, Human
Male
Middle Aged
Minority Groups
Patient Participation
Retrospective Studies
SARS-CoV-2
Socioeconomic Factors
United Kingdom
Vaccination
Young Adult

Chemicals

COVID-19 Vaccines
Influenza Vaccines